FDA Statement on Vaccines, Related Biological Products Advisory Committee Meeting

The following is attributed to FDA Commissioner Stephen M. Hahn, M.D., and Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.

Silver Spring, MD – Following yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 Coronavirus vaccine, the U.S. Food and Drug Administration (FDA) has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization.

[Read more]

Tennessee to be part of Pfizer COVID-19 Vaccine Distribution Pilot Program

Nashville, TN – Tennessee has been selected as one of four states to participate in a pilot program for delivery of the Pfizer Inc. COVID-19 Coronavirus vaccine now under development.

This program is designed to address distribution challenges posed by requirements for ultra-cold storage of the vaccine.

[Read more]

Moderna, Pfizer COVID-19 Vaccines Begin Final-Stage Testing

Washington, D.C. – “Two of the most advanced experimental coronavirus vaccines entered the pivotal phase of their studies on Monday,” Peter Loftus and Jared S. Hopkins report for The Wall Street Journal.

“The start of the pivotal Moderna vaccine trial is the latest sign that the most advanced coronavirus vaccine candidates are moving into the final stages of testing, and could be ready for wider use before year’s end if results are positive.”

[Read more]